Rocket Doctor AI Q2 FY26 net loss widens to $6.67 million; revenue rises 43% year over year to $734,028

• Rocket Doctor AI posted Q2 2026 revenue of $734,028, up 43% year over year.
• Net loss widened to $6.67 million; loss per share deepened to ($0.07).
• Gross margin fell 24 percentage points to 65% due to a revenue-mix shift as U.S. operations scale.
• U.S. completed patient visits more than doubled to 3,911; in-network reach expanded to over 24 million covered lives.
• Canada visits rose 23% year over year to 45,766; CEO Essam Hamza flagged growth from U.S. in-network payer agreements.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rocket Doctor Ai Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609010800PRIMZONEFULLFEED9819189) on September 01, 2026, and is solely responsible for the information contained therein.